Latest Clinical research Stories
Phase 3 Clinical Trial in Uncontrolled Persistent Asthma Underway TARRYTOWN, N.Y. and PARIS, May 18, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
COSTA MESA, Calif., May 18, 2015 /PRNewswire-iReach/ -- California CRO WCCT Global recently completed a study on elderly subjects
PHILADELPHIA, May 18, 2015 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it has signed a definitive agreement to acquire privately held, Silarx Pharmaceuticals, Inc.
Long-term OFEV treatment in the INPULSIS® extension study reinforces the safety and tolerability profile for up to 33 months in patients with IPF RIDGEFIELD, Conn., May 18, 2015 /PRNewswire/
ROCKVILLE, Md., May 15, 2015 /PRNewswire/ -- TissueGene, Inc. announced today that it has reached an agreement with the U.S.
SOUTH PLAINFIELD, N.J., May 15, 2015 /PRNewswire/ -- PTC Therapeutics, Inc.
Essential Compliance Services Provide Regulatory Teams with Expert Consulting, Deep Data on 52 Nations, Individual Country Reports, Database Access and E-Learning PRINCETON, N.J., May 15, 2015
BETHESDA, Md., May 14, 2015 /PRNewswire-USNewswire/ -- The Parenteral Drug Association (PDA) today is pleased to announce that Robert Califf, MD, U.S.
Conference call to be held on Thursday, May 14, 2015 at 4:30 p.m. Eastern Time BOTHELL, Wash.
The role of the patient - and user-friendly technology at the point-of-care - are becoming increasingly important to industry's transition to value-based care, says chief medical officer DUBLIN,
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).